(Q35763699)

10 August 2017

1 reference

title

Selective cyclooxygenase-2 inhibitors: similarities and differences (English)

1 reference

10 August 2017

Brune K

1

1 reference

PubMed ID

15124935

10 August 2017

Hinz B

series ordinal

2

1 reference

10 August 2017

1 January 2004

1 reference

Scandinavian Journal of Rheumatology

10 August 2017

1 reference

10 August 2017

33

1 reference

10 August 2017

1

1 reference

10 August 2017

1-6

1 reference

Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

10 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F03009740310004766

Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740310004766

Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740310004766

Pharmacological analysis of cyclooxygenase-1 in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740310004766

Cyclooxygenase-2--10 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740310004766

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740310004766

Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740310004766

Parecoxib (parecoxib sodium).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740310004766

The coxibs, selective inhibitors of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740310004766

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740310004766

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740310004766

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740310004766

Investigation of the pharmacokinetics of celecoxib by liquid chromatography-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740310004766

Celecoxib inhibits metabolism of cytochrome P450 2D6 substrate metoprolol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740310004766

Rofecoxib versus codeine/acetaminophen in postoperative dental pain: a double-blind, randomized, placebo- and active comparator-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740310004766

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740310004766

Upper gastrointestinal safety evaluation of parecoxib sodium, a new parenteral cyclooxygenase-2-specific inhibitor, compared with ketorolac, naproxen, and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740310004766

Incidence of gastroduodenal ulcers associated with valdecoxib compared with that of ibuprofen and diclofenac in patients with osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740310004766

Effect of the selective COX-2 inhibitors, celecoxib and rofecoxib in rat acute models of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740310004766

Platelet function is inhibited by non-selective non-steroidal anti-inflammatory drugs but not by cyclo-oxygenase-2-selective inhibitors in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740310004766

Potential cardioprotective actions of no-releasing aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740310004766

Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740310004766

10.1080/03009740310004766

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15124935